Sleep Apnea Devices Market Size, Growth, Share & Trends Analysis

Sleep apnea is a common disorder that affects individuals of all ages, although it is particularly prevalent among the elderly. Its health impacts are significant but often go unrecognized. A report published by the National Library of Medicine in 2023 indicates that approximately 54% of adults worldwide suffer from obstructive sleep apnea (OSA), which translates to an estimated 936 million adults aged 30 to 69 affected by the condition. Of these, around 425 million experience moderate to severe cases of OSA. This suggests that the condition is widely underdiagnosed and not fully recognized. Additionally, an article published by the European Respiratory Society in 2022 states that OSA is a prevalent chronic condition affecting over 20% of adults.

Sleep apnea may be covered under health insurance plans, although the extent of coverage can vary depending on the policy type and the severity of the condition. Similar factors affect the CPAP compliance rate among patients in Southeast Asian countries. For instance, in Singapore, the cost of a CPAP machine is significant, ranging from USD 500 to USD 1,000. Hence, high costs of CPAP devices restrain the global sleep apnea devices market, especially in developing countries. CPAP machine prices vary significantly worldwide. In the US, they typically range between USD 649 and USD 989. In the UK, prices vary based on features and brand, generally ranging from EUR 200 to EUR 1000 (approximately USD 213–USD 1070). Meanwhile, in India, CPAP machines generally cost between INR 30,000 and INR 60,000 (USD 360–USD 718).

An increasing number of people opt for home treatments due to the excessive healthcare costs in hospital settings. The home healthcare market includes many devices, including sleep apnea diagnostic and therapeutic devices. These devices and services provide patients with cost-effective healthcare. The typical cost of an in-lab sleep study averages around USD 3,000. Depending on insurance coverage, prices vary widely, ranging from USD 1,000 to over USD 10,000. Additional facility charges for hospital outpatients can further increase the total cost. Fortunately, many insurance plans provide substantial coverage for sleep studies. In contrast, at-home sleep studies are generally less expensive, ranging from USD 150 to approximately USD 1,000 or more. These studies involve minimal equipment and occur in the comfort of the participant's home without technician supervision. The cost of an at-home sleep study also depends on the specific equipment needed.

Lack of patient compliance with CPAP therapy is a crucial factor challenging the market's growth. Treatment compliance has always been an issue with sleep apnea patients, mainly due to various problems such as a lack of affordability and comfort. Patients are also unwilling to bear heavy treatment costs due to very weak reimbursements in geographies such as Asia (India and China) and the Rest of the World (Latin America, Middle East & Africa, and GCC Countries). Non-compliance is found to be more rampant among CPAP users. In 2022, according to the CMS definition used in this study, good adherence to CPAP therapy is defined as using the machine for more than four hours per night on more than five nights weekly (equivalent to 70% of nights per week). Poor adherence, therefore, indicates insufficient adherence to CPAP therapy. Failure to comply with CPAP therapy occurred in 25–50% of patients who abandoned the therapy within the first four weeks of treatment.